The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.
Open accessAbstract
A full-length cDNA for the human multidrug resistance gene 1 (MDR1) has been inserted into a retroviral vector containing a murine Harvey sarcoma virus from which the viral oncogene was deleted. Ecotropic and amphotropic virus was produced after transfection of this vector into psi-2 and PA-12 packaging cell lines. This virus conferred the full phenotype of multidrug resistance on mouse and human cell lines. Viral titers of up to 2 X 10(5) drug-resistant colonies per ml were observed. Infected cells became resistant to colchicine, vinblastine, doxorubicin, VP16 (etoposide), and puromycin, but not cisplatin, indicating that the presence of the human MDR1 gene is sufficient to cause multidrug resistance. When the dog kidney cell line MDCK was infected with the MDR1 virus, P-glycoprotein was expressed in a polarized manner on the upper surface of the cells, showing that the cloned cDNA also encodes information for polarized expression of P-glycoprotein. The MDR1 virus should be useful for introducing this drug resistance gene into a variety of cell types for biological experiments in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Self-citationChen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Self-citationMann, R., Mulligan, R. C., & Baltimore, D. (1983) · Cell · doi:10.1016/0092-8674(83)90344-6 · Cited by 1,805
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Self-citationTransformation of mammalian cells with genes from procaryotes and eucaryotes
Wigler, M., Sweet, R., Sim, G. K., Wold, B., Pellicer, A., Lacy, E., Maniatis, T., Silverstein, S., & Axel, R. (1979) · Cell · doi:10.1016/0092-8674(79)90093-x · Cited by 1,408
Ueda, K., Cardarelli, C., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.3004 · Cited by 1,063
Self-citationPolarized monolayers formed by epithelial cells on a permeable and translucent support
Cereijido, M., Robbins, E., Dolan, W., Rotunno, C., & Sabatini, D. (1978) · The Journal of cell biology · doi:10.1083/jcb.77.3.853 · Cited by 868
Isolation and expression of a complementary DNA that confers multidrug resistance
Gros, P., Neriah, Y. B., Croop, J. M., & Housman, D. E. (1986) · Nature · doi:10.1038/323728a0 · Cited by 797
Multiple-Drug Resistance in Human Cancer
Flier, J. S., Underhill, L. H., Pastan, I., & Gottesman, M. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162207 · Cited by 692
Self-citationHuman Multidrug-Resistant Cell Lines: Increased mdr 1 Expression Can Precede Gene Amplification
Shen, D.-W., Fojo, A., Chin, J. E., Roninson, I. B., Richert, N., Pastan, I., & Gottesman, M. M. (1986) · Science · doi:10.1126/science.3457471 · Cited by 603
Self-citation
Cited by
BIOCHEMICAL, CELLULAR, AND PHARMACOLOGICAL ASPECTS OF THE MULTIDRUG TRANSPORTER
Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., & Gottesman, M. M. (1999) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.39.1.361 · Cited by 2,059
Self-citationThe multidrug transporter, a double-edged sword.
Gottesman, M. M., & Pastan, I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37730-5 · Cited by 757
Self-citationHuman P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.
Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., & Hori, R. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35757-0 · Cited by 673
Self-citationMechanisms of resistance to cisplatin and carboplatin
Stewart, D. J. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.02.001 · Cited by 631
Chang, G., & Roth, C. B. (2001) · Science · doi:10.1126/science.293.5536.1793 · Cited by 619
RetractedThiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.2.2463300 · Cited by 604
Self-citationDNA Cross-Linking Agents as Antitumor Drugs
Rajski, S. R., & Williams, R. M. (1998) · Chemical Reviews · doi:10.1021/cr9800199 · Cited by 592
Chan, L. M. S., Lowes, S., & Hirst, B. H. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2003.07.003 · Cited by 582
Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein
Valverde, M. A., DÍaz, M., Sepúlveda, F. V., Gill, D. R., Hyde, S. C., & Higgins, C. F. (1992) · Nature · doi:10.1038/355830a0 · Cited by 561
The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein research
Gottesman, M. M., & Ling, V. (2006) · FEBS Letters · doi:10.1016/j.febslet.2005.12.060 · Cited by 558
Self-citationNanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Chow, E. K., Zhang, X.-Q., Chen, M., Lam, R., Robinson, E., Huang, H., Schaffer, D., Osawa, E., Goga, A., & Ho, D. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001713 · Cited by 556
Fluorescent cellular indicators are extruded by the multidrug resistance protein.
Homolya, L., Holló, Z., Germann, U. A., Pastan, I., Gottesman, M. M., & Sarkadi, B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80566-3 · Cited by 495
Self-citationSelection of Drug-Resistant Bone Marrow Cells in Vivo After Retroviral Transfer of Human MDR 1
Sorrentino, B. P., Brandt, S. J., Bodine, D., Gottesman, M., Pastan, I., Cline, A., & Nienhuis, A. W. (1992) · Science · doi:10.1126/science.1352414 · Cited by 477
Self-citationTrock, B. J., Leonessa, F., & Clarke, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.13.917 · Cited by 434
Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies.
Georges, E., Bradley, G., Gariepy, J., & Ling, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.1.152 · Cited by 384
β‐Amyloid efflux mediated by p‐glycoprotein
Lam, F. C., Liu, R., Lu, P., Shapiro, A. B., Renoir, J., Sharom, F. J., & Reiner, P. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00113.x · Cited by 380
Hunter, J., Jepson, M. A., Tsuruo, T., Simmons, N. L., & Hirst, B. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82429-2 · Cited by 370
Drug interactions in cancer therapy
Scripture, C. D., & Figg, W. D. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1887 · Cited by 366
Gill, D. R., Hyde, S. C., Higgins, C. F., Valverde, M. A., Mintenig, G. M., & Sepúlveda, F. V. (1992) · Cell · doi:10.1016/0092-8674(92)90263-c · Cited by 329
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
Gottesman, M. M., Lavi, O., Hall, M. D., & Gillet, J.-P. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103111 · Cited by 327
Self-citationKage, K., Tsukahara, S., Sugiyama, T., Asada, S., Ishikawa, E., Tsuruo, T., & Sugimoto, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10100 · Cited by 291
Gumbleton, M., & Audus, K. L. (2001) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.1119 · Cited by 286
Molecular mechanisms of drug resistance
Hayes, J. D., & Wolf, C. R. (1990) · Biochemical Journal · doi:10.1042/bj2720281 · Cited by 279
Improving Drug Potency and Efficacy by Nanocarrier-Mediated Subcellular Targeting
Murakami, M., Cabral, H., Matsumoto, Y., Wu, S., Kano, M. R., Yamori, T., Nishiyama, N., & Kataoka, K. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001385 · Cited by 262
Bicker, J., Alves, G., Fortuna, A., & Falcão, A. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.03.012 · Cited by 262
The Xenobiotic Transporter Mdr1 Enforces T Cell Homeostasis in the Presence of Intestinal Bile Acids
Cao, W., Kayama, H., Chen, M. L., Delmas, A., Sun, A., Kim, S. Y., Rangarajan, E. S., McKevitt, K., Beck, A. P., Jackson, C. B., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.11.012 · Cited by 102
MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer
Leonessa, F., Green, D., Licht, T., Wright, A., Wingate-Legette, K., Lippman, J., Gottesman, M., & Clarke, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.29 · Cited by 102
Self-citationMartins, A., Tóth, N., Ványolós, A., Béni, Z., Zupkó, I., Molnár, J., Báthori, M., & Hunyadi, A. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300424n · Cited by 59
Vágvölgyi, M., Martins, A., Kulmány, Á., Zupkó, I., Gáti, T., Simon, A., Tóth, G., & Hunyadi, A. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.12.032 · Cited by 37
Martins, A., Csábi, J., Balázs, A., Kitka, D., Amaral, L., Molnár, J., Simon, A., Tóth, G., & Hunyadi, A. (2013) · Molecules · doi:10.3390/molecules181215255 · Cited by 30
“FDA, Silver Spring, MD, USA); and a multi-drug resistant (MDR) cell line derived from PAR by transfection with pHa MDR1/A retrovirus [11].”
MethodMartins, A., Sipos, P., Dér, K., Csábi, J., Miklos, W., Berger, W., Zalatnai, A., Amaral, L., Molnár, J., Szabó-Révész, P., et al. (2015) · BioMed Research International · doi:10.1155/2015/895360 · Cited by 27
Liu, G., Lipari, P., Mollin, A., Jung, S., Teplova, I., Li, W., Ying, L., More, V., Lennox, W., Yeh, S., et al. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddad173 · Cited by 23
Csábi, J., Martins, A., Sinka, I., Csorba, A., Molnár, J., Zupkó, I., Tóth, G., Tillekeratne, L. M. V., & Hunyadi, A. (2016) · MedChemComm · doi:10.1039/c6md00431h · Cited by 13
In vitro adjuvant antitumor activity of various classes of semi-synthetic poststerone derivatives
Savchenko, R. G., Nové, M., Spengler, G., Hunyadi, A., & Parfenova, L. V. (2021) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104485 · Cited by 8
Metadata
- Authors
- Pastan, I., Gottesman, M. M., Ueda, K., Lovelace, E., Rutherford, A. V., & Willingham, M. C.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1988-06
- Volume
- 85
- Issue
- 12
- Pages
- 4486-4490
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2003263277
- Cited by
- 484
- References
- 18
- FWCI
- 6.68
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.